Level Biotechnology Inc. (TPEX:3118)
Taiwan · Delayed Price · Currency is TWD 31.75
+0.45 (1.44%)
Aug 26, 2026, 11:52 AM CST
Level Biotechnology Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 709.37 | 736.59 | 731.35 | 660.61 | 593.01 | 677.28 |
Revenue Growth | -3.54% | 0.72% | 10.71% | 11.40% | -12.44% | 0.71% |
Gross Profit Gross Profit Growth | 257.14 | 257.7 | 237.13 | 219.55 | 202.59 | 232.5 |
Operating Income Operating Income Growth | 85.41 | 83.55 | 75.32 | 67.55 | 64.9 | 78.96 |
Net Income Net Income Growth | 76.02 | 79.7 | 64.81 | 62.91 | 58.47 | 68.18 |
Earnings Per Share EPS Growth | 2.33 | 2.44 | 1.99 | 1.93 | 1.79 | 2.09 |
EPS Growth | 9.93% | 22.61% | 3.11% | 7.82% | -14.35% | 17.42% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Reagent Consumable Materials Trading Reagent Consumable Materials Trading Growth | 370.01 | 378.15 | 384.6 | 358.61 | 410.72 |
Entrusted Biotechnology Service Sales Entrusted Biotechnology Service Sales Growth | 126.86 | 136.76 | 112.16 | 99.63 | 110.27 |
Instrument and Equipment Trading Instrument and Equipment Trading Growth | 239.73 | 216.44 | 163.86 | 134.77 | 156.28 |
Total Total Growth | 736.59 | 731.35 | 660.61 | 593.01 | 677.28 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 195.38 | 210.34 | 252.78 | 467.41 | 463.5 | 472.96 |
Total Debt Total Debt Growth | 7.38 | 7.98 | 12.68 | 13.41 | 12.57 | 13.18 |
Net Cash (Debt) Net Cash Growth | 188 | 202.36 | 240.1 | 453.99 | 450.92 | 459.78 |
Net Cash Growth | -19.67% | -15.72% | -47.11% | 0.68% | -1.93% | 26.15% |
Net Cash Per Share Net Cash Per Share Growth | 5.75 | 6.19 | 7.35 | 13.90 | 13.80 | 14.08 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 103.9 | 59.61 | 64.1 | 70.21 | 65.07 | 155.95 |
Capital Expenditures CapEx Growth | -15.31 | -32.67 | -223.68 | -7.67 | -6.74 | -9.16 |
Free Cash Flow Free Cash Flow Growth | 88.6 | 26.94 | -159.58 | 62.54 | 58.33 | 146.8 |
Free Cash Flow Growth | - | - | - | 7.22% | -60.26% | 81.93% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 36.25% | 34.98% | 32.42% | 33.23% | 34.16% | 34.33% |
Operating Margin | 12.04% | 11.34% | 10.30% | 10.23% | 10.95% | 11.66% |
Pretax Margin | 13.22% | 13.25% | 11.09% | 11.91% | 12.34% | 12.53% |
Profit Margin | 10.72% | 10.82% | 8.86% | 9.52% | 9.86% | 10.07% |
FCF Margin | 12.49% | 3.66% | -21.82% | 9.47% | 9.84% | 21.67% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 2.200 | 2.200 | 1.800 | 1.700 | 1.700 | 1.900 |
Dividend Per Share Growth | 22.22% | 22.22% | 5.88% | 0% | -10.53% | 18.75% |
Dividend Yield | 6.94% | 7.13% | 6.35% | 6.62% | 7.70% | 8.48% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 13.43 | 13.44 | 16.02 | 15.71 | 15.35 | 14.26 |
P/FCF Ratio | 11.47 | 39.75 | - | 15.80 | 15.38 | 6.62 |
PS Ratio | 1.43 | 1.45 | 1.42 | 1.50 | 1.51 | 1.44 |